Debt-to-equity of Passage BIO, Inc. from 30 Sep 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Passage BIO, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 31 Dec 2025.
  • Passage BIO, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 124%, a 170% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Passage BIO, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 124% +78% +170% 31 Dec 2025
Q3 2025 93% +54% +136% 30 Sep 2025
Q2 2025 73% +38% +108% 30 Jun 2025
Q1 2025 57% +24% +74% 31 Mar 2025
Q4 2024 46% +16% +52% 31 Dec 2024
Q3 2024 39% +13% +48% 30 Sep 2024
Q2 2024 35% +12% +51% 30 Jun 2024
Q1 2024 33% +11% +52% 31 Mar 2024
Q4 2023 30% +10% +51% 31 Dec 2023
Q3 2023 26% +9.1% +53% 30 Sep 2023
Q2 2023 23% +9.4% +68% 30 Jun 2023
Q1 2023 22% +10% +91% 31 Mar 2023
Q4 2022 20% +12% +142% 31 Dec 2022
Q3 2022 17% +9.8% +131% 30 Sep 2022
Q2 2022 14% +6.9% +99% 30 Jun 2022
Q1 2022 11% +5.7% +101% 31 Mar 2022
Q4 2021 8.3% +3.7% +81% 31 Dec 2021
Q3 2021 7.5% +3.2% +73% 30 Sep 2021
Q2 2021 7% 30 Jun 2021
Q1 2021 5.6% 31 Mar 2021
Q4 2020 4.6% 31 Dec 2020
Q3 2020 4.3% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.